trump and tirzepatide Donald announces deal to reduce prices of weight loss drugs to as low as $149: What it means Trump announces major deal to

While tirzepatide appears to provide greater weight loss than semaglutide in this population, head-to-head RCTs are not yet available.

Semaglutide is a GLP-1 receptor agonist that is used to treat diabetes and obesity

This study aims to comprehensively review the impact of GLP-1 RAs on various body systems, emphasizing both positive and negative effects while addressing existing knowledge gaps in the literature

Tirzepatide is a medication approved for the treatment of type 2 diabetes, offering a new approach to managing high blood sugar

Good source of vitamin A

from GLP-1 Trends by CivicScience: Weight-Loss Pills, Dining Out Motivations, and Grocery Store Preferences